Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | APAF1 | O14727 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | APP | P05067 | 3/20 | 0.45 |
| ▸ | EP300 | Q09472 | 1/20 | 0.44 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.44 |
| ▸ | TNKS | O95271 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 4/20 | 0.43 |
| ▸ | QPCT | Q16769 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | SHBG | P04278 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | MGLL | Q99685 | 2/20 | 0.39 |
| ▸ | CCNC | P24863 | 1/20 | 0.38 |
| ▸ | CDK8 | P49336 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10777972 | 0.74 | L3MBTL1 (0.56) | L3MBTL1APAF1USP2RAB9AAPP | |
| SCHEMBL3759716 | 0.73 | MGLL (0.65) | L3MBTL1MAPTFAAHMGLL | |
| SCHEMBL339623 | 0.73 | EP300 (0.39) | L3MBTL1APPEP300PGRFAAH | |
| SCHEMBL7750137 | 0.73 | EP300 (0.78) | L3MBTL1RAB9AEP300QPCTMAPT | |
| SCHEMBL2207387 | 0.73 | ALDH1A1 (0.40) | RAB9ATNKSSHBGMAPTFAAH | |
| SCHEMBL15080535 | 0.72 | APP (0.57) | L3MBTL1APAF1USP2RAB9AAPP | |
| SCHEMBL14076002 | 0.71 | APP (0.62) | L3MBTL1APAF1USP2RAB9AAPP | |
| SCHEMBL14075998 | 0.71 | APP (0.58) | L3MBTL1APAF1USP2RAB9AAPP | |
| SCHEMBL25470835 | 0.70 | APP (0.52) | L3MBTL1APAF1USP2RAB9AAPP | |
| SCHEMBL20468570 | 0.70 | L3MBTL1 (0.66) | L3MBTL1APAF1USP2RAB9AAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12638394-B2 | Skin sensitization measuring reagent, method for measuring skin sensitization, and compound | FUJIFILM CORPORATION (JP) | 2026-05-26 | — | — | US | disclosed |
| EP-4036570-B1 | REAGENT FOR MEASURING SKIN SENSITIZATION, METHOD FOR MEASURING SKIN SENSITIZATION, AND COMPOUND | FUJIFILM CORP (JP) | 2025-03-05 | — | — | EP | disclosed |
| EP-4234537-A1 | REAGENT FOR MEASURING SKIN SENSITIZATION, COMPOUND, AND METHOD FOR MEASURING SKIN SENSITIZATION | FUJIFILM Corporation (JP) | 2023-08-30 | — | — | EP | disclosed |
| US-20230258569-A1 | REAGENT FOR MEASURING SKIN SENSITIZATION, COMPOUND, AND METHOD FOR MEASURING SKIN SENSITIZATION | FUJIFILM CORPORATION (JP) | 2023-08-17 | — | — | US | disclosed |
| EP-4036570-A1 | REAGENT FOR MEASURING SKIN SENSITIZATION, METHOD FOR MEASURING SKIN SENSITIZATION, AND COMPOUND | FUJIFILM Corporation (JP) | 2022-08-03 | — | — | EP | disclosed |
| US-20220214276-A1 | SKIN SENSITIZATION MEASURING REAGENT, METHOD FOR MEASURING SKIN SENSITIZATION, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2022-07-07 | — | — | US | disclosed |
| WO-2022085762-A1 | REAGENT FOR MEASURING SKIN SENSITIZATION, COMPOUND, AND METHOD FOR MEASURING SKIN SENSITIZATION | 富士フイルム株式会社 | 2022-04-28 | — | — | WO | disclosed |
| WO-2021060477-A1 | REAGENT FOR MEASURING SKIN SENSITIZATION, METHOD FOR MEASURING SKIN SENSITIZATION, AND COMPOUND | 富士フイルム株式会社 | 2021-04-01 | — | — | WO | disclosed |
| EP-1646395-B1 | METHODS AND COMPOSITIONS FOR REGULATING LYMPHOCYTE ACTIVITY | CURIS INC (US) | 2014-11-05 | — | — | EP | disclosed |
| US-8637562-B2 | Methods for detecting sulfhydryl-containing compounds in a biological test sample | THERAVANCE, INC. (US) | 2014-01-28 | — | — | US | disclosed |
| EP-1036092-A2 | HYDROPHOBICALLY-MODIFIED PROTEIN COMPOSITIONS AND METHODS | BIOGEN, INC. (US) | 2000-09-20 | — | — | EP | disclosed |
| EP-1028741-A1 | REGULATION OF EPITHELIAL TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO | Ontogeny, Inc. (US) | 2000-08-23 | — | — | EP | disclosed |
| WO-2000035948-A1 | METHODS AND COMPOSITIONS FOR TREATING DISORDERS INVOLVING EXCITOTOXICITY | BIOGEN, INC. (US) | 2000-06-22 | — | — | WO | disclosed |
| EP-1009424-A2 | REGULATION OF MUSCLE TISSUES BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO | Ontogeny, Inc. (US) | 2000-06-21 | — | — | EP | disclosed |
| WO-2000027422-A2 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PERIPHERAL NEUROPATHIES | BIOGEN, INC. (US) | 2000-05-18 | — | — | WO | disclosed |
| WO-1999028343-A9 | HYDROPHOBICALLY-MODIFIED PROTEIN COMPOSITIONS AND METHODS | BIOGEN INC (US) | 1999-10-14 | — | — | WO | disclosed |
| WO-1999028343-A2 | HYDROPHOBICALLY-MODIFIED PROTEIN COMPOSITIONS AND METHODS | BIOGEN, INC. (US) | 1999-06-10 | — | — | WO | disclosed |
| WO-1999020298-A1 | REGULATION OF EPITHELIAL TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO | ONTOGENY, INC. (US) | 1999-04-29 | — | — | WO | disclosed |
| WO-1999010004-A2 | REGULATION OF MUSCLE TISSUES BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO | ONTOGENY, INC. (US) | 1999-03-04 | — | — | WO | disclosed |
| US-5790627-A | Method and apparatus for observing a specimen using an X-ray microscope | RESEARCH DEVELOPMENT CORP. (JP) | 1998-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12638394-B2 | Skin sensitization measuring reagent, method for measuring skin sensitization, and compound | HRH1, HRH4, CUTA | L3MBTL1 3292/4885APAF1 4512/4885USP2 2523/4885 |
| US-20230258569-A1 | REAGENT FOR MEASURING SKIN SENSITIZATION, COMPOUND, AND METHOD FOR MEASURING SKIN SENSITIZATION | TST, CUTA, HNMT | L3MBTL1 4306/4885APAF1 4049/4885USP2 1275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.